Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
4(31%)
Results Posted
22%(2 trials)

Phase Distribution

Ph phase_3
1
8%
Ph phase_4
2
15%
Ph phase_2
1
8%
Ph not_applicable
8
62%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(4)
Completed(9)

Detailed Status

Completed9
Active, not recruiting3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 42 (16.7%)
N/A8 (66.7%)

Trials by Status

active_not_recruiting323%
completed969%
recruiting18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13